U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H5N3O
Molecular Weight 111.102
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Cytosine

SMILES

NC1=NC(=O)NC=C1

InChI

InChIKey=OPTASPLRGRRNAP-UHFFFAOYSA-N
InChI=1S/C4H5N3O/c5-3-1-2-6-4(8)7-3/h1-2H,(H3,5,6,7,8)

HIDE SMILES / InChI

Molecular Formula C4H5N3O
Molecular Weight 111.102
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Cytosine is a pyrimidine nucleobase, one of the five main bases of nucleic acids. In DNA and RNA cytosine is paired with guanine. Only small amounts of cytosine administered with food are incorporated in DNA. The majority of cytosine is synthesized de-novo starting from carbamoyl phosphate.

CNS Activity

Curator's Comment: Cytosine administered with food does not pass through blood-brain barrier. Cytosine is synthesized in the brain de-novo.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
The mechanism of DNA cytosine-5 methylation. Kinetic and mutational dissection of Hhai methyltransferase.
2001-06-15
Chimeras between single-stranded DNA-binding proteins from Escherichia coli and Mycobacterium tuberculosis reveal that their C-terminal domains interact with uracil DNA glycosylases.
2001-05-18
Optimized RNA targets of two closely related triple KH domain proteins, heterogeneous nuclear ribonucleoprotein K and alphaCP-2KL, suggest Distinct modes of RNA recognition.
2001-05-18
Cytosine methylation enhances mitoxantrone-DNA adduct formation at CpG dinucleotides.
2001-05-11
Actinomycin D binds strongly to d(TGTCATTG), a single-stranded DNA devoid of GpC sites.
2001-05-01
Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
2001-05-01
Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferation.
2001-05-01
Evolution of endogenous retrovirus-like elements of the woolly mammoth (Mammuthus primigenius) and its relatives.
2001-05
Pseudogenes, junk DNA, and the dynamics of Rickettsia genomes.
2001-05
The elevated GC content at exonic third sites is not evidence against neutralist models of isochore evolution.
2001-05
Glucocorticoid-induced DNA demethylation and gene memory during development.
2001-04-17
Association study of CAG repeats in the KCNN3 gene in Japanese patients with schizophrenia, schizoaffective disorder and bipolar disorder.
2001-04-15
Potent inhibition of hemangiosarcoma development in mice by cidofovir.
2001-04-15
Single molecule DNA sequencing in submicrometer channels: state of the art and future prospects.
2001-04-13
15-mer DNA duplexes containing an abasic site are thermodynamically more stable with adjacent purines than with pyrimidines.
2001-04-03
Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications.
2001-04-03
Suicide gene therapy: possible applications in haematopoietic disorders.
2001-04
The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
2001-04
DNA methylation learns to fly.
2001-04
Low-energy (5-40 eV) electron-stimulated desorption of anions from physisorbed DNA bases.
2001-04
Solution structure of the SL1 RNA of the M1 double-stranded RNA virus of Saccharomyces cerevisiae.
2001-04
Base sequence-specific attack of stilbene estrogen metabolite(s) on the mitochondrial DNA: implications in the induction of instability in the mitochondrial genome in the kidney of Syrian hamsters.
2001-04
A-like guanine-guanine stacking in the aqueous DNA duplex of d(GGGGCCCC).
2001-03-23
Solution structure of an A-tract DNA bend.
2001-03-09
Molecular topology of polycyclic aromatic carcinogens determines DNA adduct conformation: a link to tumorigenic activity.
2001-03-09
High guanine-cytosine content is not an adaptation to high temperature: a comparative analysis amongst prokaryotes.
2001-03-07
Hierarchy of DNA damage recognition in Escherichia coli nucleotide excision repair.
2001-03-06
Tetraplex formation by the progressive myoclonus epilepsy type-1 repeat: implications for instability in the repeat expansion diseases.
2001-03-02
Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity.
2001-03
Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children.
2001-03
Effect of chemical modifications of cytosine and guanine in a CpG-motif of oligonucleotides: structure-immunostimulatory activity relationships.
2001-03
Epigenetic regulation of human bone morphogenetic protein 6 gene expression in prostate cancer.
2001-03
Topical cidofovir for bowenoid papulosis in an HIV-infected patient.
2001-03
Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines.
2001-02-16
Suicide gene therapy for premalignant disease: a new strategy for the treatment of intraepithelial neoplasia.
2001-02
Isolation and frontier molecular orbital investigation of bioactive quinone-methide triterpenoids from the bark of Salacia petenensis.
2001-02
Size constraints for targeting post-transcriptional gene silencing and for RNA-directed methylation in Nicotiana benthamiana using a potato virus X vector.
2001-02
Characterization of DNA damage at purine residues in oligonucleotides and calf thymus DNA induced by the mutagen 1-nitrosoindole-3-acetonitrile.
2001-02
Confounded cytosine! Tinkering and the evolution of DNA.
2001-02
Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individuals.
2001-02
Failure of cidofovir to reduce CMV-antigenemia in a child transplanted from a matched unrelated donor.
2001-02
In-situ FTIR study on adsorption and oxidation of native and thermally denatured calf thymus DNA at glassy carbon electrodes.
2001-01-31
Surveying CpG methylation at 5'-CCGG in the genomes of rice cultivars.
2001-01
Murine recombinant prion protein induces ordered aggregation of linear nucleic acids to condensed globular structures.
2001
A simple model based on mutation and selection explains trends in codon and amino-acid usage and GC composition within and across genomes.
2001
Prophylaxis against herpesvirus infections in transplant recipients.
2001
Suicide gene therapy for pediatric tumors.
2001
Imaging biochemistry: applications to breast cancer.
2001
UAG readthrough in mammalian cells: effect of upstream and downstream stop codon contexts reveal different signals.
2001
Regulation of gene expression by GC-rich DNA cis-elements.
2001
Patents

Patents

Sample Use Guides

In Vivo Use Guide
As a component of DNA, cytosine is ingested with a normal diet. Normally, a major amount of cytosine is excreted, and a small amount is incorporated into DNA of the gastrointestinal tract.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:34:30 GMT 2025
Edited
by admin
on Mon Mar 31 17:34:30 GMT 2025
Record UNII
8J337D1HZY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-27787
Preferred Name English
Cytosine
INCI   MI   USP-RS  
INCI  
Official Name English
LAMIVUDINE IMPURITY C [USP IMPURITY]
Common Name English
4-AMINOURACIL
Common Name English
CYTOSINE [MI]
Common Name English
Cytosine [WHO-DD]
Common Name English
CYTOSINIMINE
Systematic Name English
LAMIVUDINE IMPURITY E [EP IMPURITY]
Common Name English
CYTOSINE [USP-RS]
Common Name English
4-AMINOPYRIMIDIN-2(1H)-ONE
Systematic Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/07/476
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
LOINC 79658-1
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
NCI_THESAURUS C789
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
LOINC 79655-7
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
LOINC 79683-9
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
Code System Code Type Description
RXCUI
1372540
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
PRIMARY RxNorm
DAILYMED
8J337D1HZY
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
PRIMARY
EVMPD
SUB34834
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
PRIMARY
MESH
D003596
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
PRIMARY
SMS_ID
100000128119
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
PRIMARY
RS_ITEM_NUM
1162148
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
PRIMARY
CAS
71-30-7
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
PRIMARY
FDA UNII
8J337D1HZY
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
PRIMARY
ECHA (EC/EINECS)
200-749-5
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
PRIMARY
NCI_THESAURUS
C410
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
PRIMARY
MERCK INDEX
m4062
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
PRIMARY Merck Index
WIKIPEDIA
CYTOSINE
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
PRIMARY
NSC
27787
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
PRIMARY
EPA CompTox
DTXSID4044456
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
PRIMARY
CHEBI
16040
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
PRIMARY
PUBCHEM
597
Created by admin on Mon Mar 31 17:34:30 GMT 2025 , Edited by admin on Mon Mar 31 17:34:30 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SOLVATE->ANHYDROUS
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
PARENT -> IMPURITY
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Related Record Type Details
ACTIVE MOIETY